These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16363597)

  • 21. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
    Tsukada K; Katoh H; Miyazaki T; Kuwano H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():486-8. PubMed ID: 16363585
    [No Abstract]   [Full Text] [Related]  

  • 23. [Triple therapy for eradication of Helicobacter pylori in Japan].
    Takeda H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():409-13. PubMed ID: 16363569
    [No Abstract]   [Full Text] [Related]  

  • 24. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori.
    Wilhelm SM; Johnson JL; Kale-Pradhan PB
    Ann Pharmacother; 2011 Jul; 45(7-8):960-6. PubMed ID: 21693698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current role of acid suppressants in the treatment of peptic ulcer disease].
    Takeda H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():371-6. PubMed ID: 11979809
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of clarithromycin in eradicating Helicobacter pylori.
    Satoh K; Kimura K; Takimoto T; Kihira K; Taniguchi Y; Saifuku K
    J Gastroenterol; 1996 Nov; 31 Suppl 9():53-5. PubMed ID: 8959520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

  • 32. [Guidelines in the management of H. pylori infection in Japan].
    Asaka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():12-6. PubMed ID: 16363496
    [No Abstract]   [Full Text] [Related]  

  • 33. Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
    Rokkas T; Sechopoulos P; Robotis J; Pistiolas D
    Am J Gastroenterol; 2006 Aug; 101(8):1938; author reply 1938-9. PubMed ID: 16928256
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
    Oka M; Ichinose M; Fujishiro M; Omata M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():461-4. PubMed ID: 16363579
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of lactoferrin on H. pylori colonization].
    Imoto I; Okuda M; Nakazawa T; Yamauchi K; Adachi Y
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():577-81. PubMed ID: 16363605
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
    Isakov VA
    Eksp Klin Gastroenterol; 2004; (3):40-4. PubMed ID: 15560400
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical inquiries. What regimens eradicate Helicobacter pylori?
    Malaty W; Stigleman S; Hansen LB
    J Fam Pract; 2003 Oct; 52(10):799-803. PubMed ID: 14529606
    [No Abstract]   [Full Text] [Related]  

  • 39. [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
    Grinevich VB; Sablin OA; Gubonina IV; Dobrenko VA
    Eksp Klin Gastroenterol; 2005; (2):95-9. PubMed ID: 15932163
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.